Trial: 202005098

NF110: Open-label, Phase 2 Clinical Trial of Crizotinib for Children and Adults with Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Phase

II

Principal Investigator

Armstrong, Amy

Disease Site

Brain and Nervous System

Learn more about this study at: clinicaltrials.gov